Pleasanton-based Cooper to sell its Japanese contact lens operation | June 7, 2013 | Pleasanton Weekly | |

Pleasanton Weekly

- June 7, 2013

Pleasanton-based Cooper to sell its Japanese contact lens operation

Firm will focus on 'delivering shareholder value' through U.S. business, CEO says

by Jeb Bing

The Cooper Companies, a global medical device and vision care company headquartered in Pleasanton, has reached an agreement to sell Aime, its rigid gas permeable contact lens and solutions business in Japan, to Nippon Contact Lens Inc.

Financial terms of the transaction were not disclosed.

Commenting on the transaction, Robert S. Weiss, Cooper's president and chief executive officer, said the decision to divest Aime "is consistent with CooperVision's strategy to focus on its core soft contact lens business."

"Additionally, Aime has declining revenue and lower than average company margins," he added. "The business was obtained in 2010 as part of a very successful acquisition which included obtaining the rights to sell Biofinity in Japan."

The divestiture is subject to numerous conditions but is expected to close during Cooper's fourth quarter of fiscal 2013. Cooper expects the related charge to negatively impact its fiscal 2013 GAAP earnings per share by $0.25-$0.35. This charge will be excluded from its fiscal 2013 non-GAAP earnings per share.

Post divestiture, Cooper expects the transaction to be neutral to earnings per share. Aime revenues for fiscal 2012 and the first quarter of fiscal 2013 were $32.9 million and $7.2 million, respectively.